News Release

09/04/2014
Release
Tokyo Administrative Office Relocation
09/01/2014
Release
Re-assignment of Industry Category
07/01/2014
Release
F351 Phase II Clinical Trial Approval
06/11/2014
Event Calendar
World Orphan Drug Congress Asia
05/09/2014
Release
Patent Allowance for Etuary and F351 in the U.S.
03/19/2014
Release
Notice for completion of the registration of incorporation of a subsidiary
02/27/2014
Release
Notice of Changing of Accounting Auditor
02/27/2014
Release
Announcement of the 13th Annual General Shareholder Meeting
02/27/2014
Release
Notice for the drug price and sales commencement for Etuary
02/03/2014
Release
Notice for Exercise of the 37th Round of Stock Options in January, 2014
01/27/2014
Release
Notice for establishment of distributors
01/17/2014
Release
Notice for Large Volume Exercise and Completion of the 37th Round of Stock Option
01/14/2014
Release
Notice for F647 commercial name
01/06/2014
Release
GNI Group Receives Manufacture Approval for F647 from China FDA for First Idiopathic Pulmonary Fibrosis Drug in China
01/06/2014
Release
（Amendment）GNI Group Receives Manufacture Approval for F647 from China FDA for First Idiopathic Pulmonary Fibrosis Drug in China